Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Tough

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Nature Communications|April 15, 2020
Single-cell transcriptomics identifies an effectorness gradient shaping the response of CD4<sup>+</sup> T cells to cytokinesEddie Cano-Gamez, Blagoje Soskic, Theodoros I Roumeliotis, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2007
In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infectionBecca Asquith, Yan Zhang, Angelina J Mosley, et al.
Journal of Medicinal Chemistry|December 22, 2016
Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical ProbePhilip G Humphreys, Paul Bamborough, Chun-Wa Chung, et al.
The Journal of Experimental Medicine|June 10, 2020
BACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppressionFrancis M Grant, Jie Yang, Rabab Nasrallah, et al.
Nature Genetics|May 26, 2022
Immune disease risk variants regulate gene expression dynamics during CD4<sup>+</sup> T cell activationBlagoje Soskic, Eddie Cano-Gamez, Deborah J Smyth, et al.
British Journal of Clinical Pharmacology|June 2, 2022
Phase 1 and preclinical profiling of ESM-HDAC391, a myeloid-targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaeniaRebecca C Furze, Judit Molnar, Nigel J Parr, et al.
Frontiers in Immunology|May 10, 2021
Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen JointsAndrew Y F Li Yim, Enrico Ferrero, Klio Maratou, et al.
Frontiers in Immunology|October 30, 2020
HDAC3 Mediates the Inflammatory Response and LPS Tolerance in Human Monocytes and MacrophagesMohammed Ghiboub, Jing Zhao, Andrew Y F Li Yim, et al.
Nature Communications|May 24, 2022
Robust temporal map of human in vitro myelopoiesis using single-cell genomicsClara Alsinet, Maria Nascimento Primo, Valentina Lorenzi, et al.
Vaccine|February 6, 2008
Evaluation of the effects of human leukocyte IFN-alpha on the immune response to the HBV vaccine in healthy unvaccinated individualsPaola Rizza, Imerio Capone, Francesca Urbani, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Nature Communications|April 15, 2020
Single-cell transcriptomics identifies an effectorness gradient shaping the response of CD4<sup>+</sup> T cells to cytokinesEddie Cano-Gamez, Blagoje Soskic, Theodoros I Roumeliotis, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2007
In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infectionBecca Asquith, Yan Zhang, Angelina J Mosley, et al.
Journal of Medicinal Chemistry|December 22, 2016
Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical ProbePhilip G Humphreys, Paul Bamborough, Chun-Wa Chung, et al.
The Journal of Experimental Medicine|June 10, 2020
BACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppressionFrancis M Grant, Jie Yang, Rabab Nasrallah, et al.
Nature Genetics|May 26, 2022
Immune disease risk variants regulate gene expression dynamics during CD4<sup>+</sup> T cell activationBlagoje Soskic, Eddie Cano-Gamez, Deborah J Smyth, et al.
British Journal of Clinical Pharmacology|June 2, 2022
Phase 1 and preclinical profiling of ESM-HDAC391, a myeloid-targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaeniaRebecca C Furze, Judit Molnar, Nigel J Parr, et al.
Frontiers in Immunology|May 10, 2021
Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen JointsAndrew Y F Li Yim, Enrico Ferrero, Klio Maratou, et al.
Frontiers in Immunology|October 30, 2020
HDAC3 Mediates the Inflammatory Response and LPS Tolerance in Human Monocytes and MacrophagesMohammed Ghiboub, Jing Zhao, Andrew Y F Li Yim, et al.
Nature Communications|May 24, 2022
Robust temporal map of human in vitro myelopoiesis using single-cell genomicsClara Alsinet, Maria Nascimento Primo, Valentina Lorenzi, et al.
Vaccine|February 6, 2008
Evaluation of the effects of human leukocyte IFN-alpha on the immune response to the HBV vaccine in healthy unvaccinated individualsPaola Rizza, Imerio Capone, Francesca Urbani, et al.
Pageof 9